SEC Form 4 · accession 0001140361-17-026127
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marcus E. Smith
Director
Period of report
Jun 22, 2017
Accepted (ET)
Jun 26, 2017 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $3.31 | Jun 22, 2017 | A | 30,000 | A | — | Jun 22, 2027 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1This option is exercisable with respect to 15,000 shares on the earlier of (i) June 22, 2018 or (ii) the date of the issuer's 2018 Annual Meeting of Stockholders, subject to the grantee's continued service on the Board of Directors of the issuer through this date. This option is exercisable with respect to the remaining 15,000 shares on the earlier of (i) June 22, 2019 or (ii) the date of the issuer's 2019 Annual Meeting of Stockholders, subject to the grantee's continued service on the Board of Directors of the issuer through this date.